BCL9 anticorps (AA 1036-1135)

N° du produit ABIN2209538

Détail du produit anti-BCL9 anticorps

Antigène: BCL9 (B-Cell CLL/lymphoma 9 (BCL9))

Épitope: AA 1036-1135

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp BCL9 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF)

Réactivité croisée: Humain

Réactivité croisée (Details): Calculated cross reactivity: Hu

Attributs du produit: BCL9 (B Cell CLL/Lymphoma 9 Protein, B Cell Lymphoma 9 Protein, Bcl-9, Protein Legless Homolog)

Purification: Purified by Protein A affinity chromatography.

Immunogène: Partial recombinant corresponding to aa1036-1135 from human BCL9 (NP_004317) with GST tag. MW of the GST tag alone is 26kD.

Clone: 2D4

Isotype: IgG1 kappa

Information d'application

Indications d'application: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Supplied as a liquid in PBS, pH 7.2.

Stock: -20 °C

Stockage commentaire: -20°C

Détails sur BCL9

Antigène: BCL9 (B-Cell CLL/lymphoma 9 (BCL9))

Autre désignation: BCL9 (BCL9 Produits)

Synonymes: anticorps lgs, anticorps xbcl9, anticorps legless, anticorps MGC83888, anticorps BCL9, anticorps 2610202E01Rik, anticorps 8030475K17Rik, anticorps A330041G23Rik, anticorps Gm130, anticorps LGS, anticorps B-cell CLL/lymphoma 9 L homeolog, anticorps B-cell CLL/lymphoma 9, anticorps B cell CLL/lymphoma 9, anticorps bcl9.L, anticorps BCL9, anticorps Bcl9

NCBI Accession: NM_004326, NP_004317

Pathways: Stem Cell Maintenance